The Missing Middle: India’s Real Healthcare Gap

India produces some of the world’s most scientifically capable healthcare professionals and some of its most robust clinical data. India also has one of the world’s fastest-growing healthcare markets, a maturing biotech sector, and a device and diagnostics industry finding global ambition. Between these facts sits a gap almost nobody names.

It is not a talent gap. Every year, India graduates thousands of MDs, PharmDs, and life science researchers with training that stands comparison anywhere in the world. It is not a science gap either. Indian companies generate credible clinical data, and Indian institutions publish research of real quality.

It is a strategy gap: the missing layer of professionals, frameworks, and disciplines that turn scientific capability into clinical impact. Positioning, so a product’s science answers the questions clinicians are actually asking. Evidence planning, so studies are designed for the decisions they need to inform. Scientific communication, so data reaches the people whose practice it should change. These are the disciplines that decide whether a good product is actually used, and whether good science actually matters.

Global pharmaceutical companies solved this decades ago. They built large Medical Affairs organizations, evidence strategy functions, and scientific communication teams, and they treat these as core strategic infrastructure. Watch where the global industry invests when a product matters, and you will find this layer at the centre of it.

Indian companies, startups, and academic institutions are building world-class science with almost none of this layer. Most cannot justify a full in-house function, and the discipline itself is still young in the Indian market. The consequences are visible everywhere once you look. Products with strong data that never earn clinical preference, losing to competitors with weaker science and better strategy. Graduates with strong credentials who cannot enter the industry that needs them, because nobody taught them the industry’s language. Institutions producing research that never travels beyond the journal it was published in.

The cost of the missing middle is paid three times: by companies in unrealised product potential, by professionals in unrealised careers, and ultimately by patients, who wait longer than they should for science that already exists.

The encouraging part is that this gap is closeable. It does not require new regulation, new capital on a grand scale, or a generation of waiting. It requires the deliberate building of a discipline: training people in it, embedding it in organizations, and treating strategy with the same rigor Indian healthcare already applies to science.

The science is not the problem. The bridge is missing. Building that bridge, for organizations and for the people who will staff it, is the work.

Key message boxes:

• India’s healthcare gap is not talent or science. It is the strategic layer connecting them.
• The cost is paid three times: in product potential, in careers, and in patient access.
• The gap is closeable. It requires a discipline to be built, not a miracle.

This article represents the professional views of the authors, shared for educational purposes. It does not constitute medical, legal, or investment advice.